FCC Authority to Act as Agent Letter

File Info : application/pdf, 1 Pages, 155.98KB

Array
(
    [0] => Array
        (
            [url_sha] => 1a2205432f24e7bb1f10449007a24069c31c41e17d87417f8323811faf08d23a
            [source] => fccid
            [url] => https://apps.fcc.gov/eas/GetApplicationAttachment.html?id=4616193
            [href_text] => FCC Authority to Act as Agent Letter
            [href_description] => EPS Bio Technology Corp. D064 Self-Monitoring Blood Glucose System 2AQBR-D064 2AQBRD064 d064
            [http_status] => 200
            [http_lastmod] => 0000-00-00 00:00:00
            [http_contenttype] => application/pdf
            [http_filename] => GetApplicationAttachment.html?id=4616193
            [http_size] => 159725
            [file_sha256] => 0ef8b6d39b708145373a7657b816ad0c272db3de6300f78fa8000ea4e0c6b911
            [domain] => document.fccid
        )

)

Array
(
    [0] => Array
        (
            [id] => 4616193
            [file_sha256] => 
            [applicationId] => H8a1+u8OvXmOpO0o3Zfriw==
            [description] => FCC Authority to Act as Agent Letter
            [shortTermConfidential] => No
            [permanentConfidential] => No
            [supercede] => No
            [exhibitType] => Cover Letter(s)
            [fileType] => Adobe Acrobat PDF
            [displayType] => pdf
            [fileSize] => 159727
            [submissionDate] => 2020-02-06 00:00:00
            [dateAvailable] => 2020-02-07 00:00:00
            [creationDate] => 
            [producer] => 
            [modDate] => 
            [title] => 
            [creator] => 
            [author] => 
            [pages] => 
            [realSize] => 
            [html] => 0
            [png] => 0
            [txt] => 0
            [version] => 0
            [source] => 0
            [fccId] => 2AQBR-D064
            [cleanFccId] => 2AQBRD064
            [exif] => 0
        )

)